 Marinus Pharmaceuticals, Inc. NASDAQ:MRNS Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Sasha Ellis - VP, Corporate Affairs IR Scott Braunstein - CEO, President Director Christy Shafer - Chief Commercial Officer Joseph Hulihan - Chief Medical Officer Steven Pfanstiel - CFO Treasurer Conference Call Participants Andrew Tsai - Jefferies Charles Duncan - Cantor Fitzgerald Co. Douglas Tsao - H.C. Wainwright Co. Jay Olson - Oppenheimer Michael Higgins - Ladenburg Thalmann Co. Brian Skorney - Robert W. 